Piedmont Pharmaceuticals Prepares for Veterinary Companion Animal Product Launches

GREENSBORO, N.C. -- Piedmont Pharmaceuticals, LLC, an innovative pharmaceutical company focused on veterinary market pharmaceuticals, announced its hiring of Mr. Stan Cruitt as Vice President of Marketing Services. "We couldn't be more pleased to have Stan join our team. His longstanding record of animal health pharmaceuticals launch success represents perfect timing as we at Piedmont are beginning to prepare for significant product launches," said Roland Johnson, founder, CEO and Board member of Piedmont Pharmaceuticals. "His record on market and product evaluation, product positioning and communications/marketing strategies stands against the very best in the industry. Stan was honored as one of the top marketers in the US by Advertising Age and Newsweek after one of his major product launches," adds Mr. Johnson.

NCTechNews is published by Innovative Public Relations, Inc. (www.innovativepublicrelations.com), a Research Triangle-based consultancy providing PR and media relations services to help clients achieve their business development and organizational goals. NCTechNews supplements quality reporting provided by respected media outlets throughout North Carolina and the United States.

Cruitt has held marketing, management and executive positions at Merck, Ciba and Novartis in the animal health industry and has been President and/or founder of three human healthcare startups. Cruitt is the latest addition to Piedmont's growing cadre of industry leaders joining their management team. A team which now, in total, are responsible for the development and/or marketing and launch of many of the leading veterinary pharmaceuticals today; representing nearly a third of the total US sales dollars for the companion animal veterinary pharmaceutical industry.

"I've reviewed the Piedmont product development portfolio and can say with confidence that they have several products that will become the leader in their respective product categories in veterinary medicine," said Cruitt. "Each will be a prescription product and a valuable addition to the veterinarian's practice."

"We have 25 new veterinary pharmaceutical products (New Animal Drug Application (NADA) and Abbreviated NADA (ANADA)) in various levels of development, with a steady stream of approvals expected annually through 2020," adds Mr. Johnson.

About Piedmont Pharmaceuticals, LLC
Piedmont Pharmaceuticals, LLC, is an innovative development and marketing company focused on veterinary pharmaceuticals. Piedmont is a world-class animal health pharmaceutical company with an objective of being among the top seven largest companion animal pharmaceutical companies in the US by 2020. Towards accomplishing that goal, Piedmont is continuing to make significant progress with its current product development portfolio.